Alexei V. Mikhailov, MD, PhD
- Associate Professor, Pathology (Winston-Salem)

Alexei V. Mikhailov, MD, PhD
- Associate Professor, Pathology (Winston-Salem)
- Education
- MD, St. Petersburg State Pediatric Medical Academy , Russian Federation, 1985
- PhD, Columbia University College of Physicians and Surgeons, 1998
- Residency
- Pathology, Mount Sinai School of Medicine of New York University, 2015
- Fellowship
- Nephropathology, University of North Carolina Chapel Hill School of Medicine, 2017
- Board Certifications
- American Board of Pathology, Pathology-Anatomic
- Positions
- Associate Professor, Pathology (Winston-Salem)
- Departments and Affiliations
- Pathology (Winston-Salem)
Research
- Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis. Shinohara M, Mikhailov AV, Aguirre-Ghiso JA, Rieder CL. Mol. Biol. Cell. 2006 Dec; 17(12):5227-40.
- The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Mikhailov A, Shinohara M, Rieder CL. Cell Cycle. 2005 Jan; 4(1):57-62.
- Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. Mikhailov A, Shinohara M, Rieder CL. J. Cell Biol. 2004 Aug; 166(4):517-26.
- The pulse of mitosis. Rieder CL, Mikhailov A. Nat. Biotechnol. 2004 Mar; 22(3):279-80.
- DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Mikhailov A, Cole RW, Rieder CL. Curr. Biol. 2002 Oct; 12(21):1797-806.